Today’s Intrinsic Values
Stock Overview
Rundown***
ANTM – ANTHEM, INC. (HQ: USA/Industry: Health Care Providers & Services)
Anthem’s purpose is to improve the health of humanity. The company looks at whole health and its most critical drivers: social, behavioral and physical. Believing in working together to achieve its goals of improving lives and communities, simplifying healthcare and expecting more. Striving to accomplish these goals through a collaborative focus on execution and delivering for those the company serves in order to become a lifetime, trusted health partner.
Recent 10-Year Financial Summary
Revenue: Increased 125%, with 0 declining years
EPS: Increased 202%, with 3 declining years
BV: Increased 89%, with 1 declining year
FCF: Increased 231%, with 4 declining years
Share Count: Decreased -24%
Dividend: Increased 293%, with 0 declining years
To value the business at their current market price the company would need more than a 11% per year growth for the next 10-years #SEC filing link:
https://www.sec.gov/edgar/browse/?CIK=1156039&owner=exclude
AMCX – AMC NETWORKS INC. (HQ: USA/Industry: Media)
AMC Networks is a global entertainment company known for its popular and award-winning content. The company distributes content to audiences globally on an ever-expanding array of distribution platforms, including: linear networks, subscription streaming services, and social media platforms, as well as through content licensing arrangements.
Recent 10-Year Financial Summary
Revenue: Increased 127%, with 1 declining year
EPS: Increased 205%, with 4 declining years
BV: Increased -262%, with 1 declining year
FCF: Decreased -82%, with 5 declining years
Share Count: Decreased -40%
Company does not pay a dividend
The stock currently trades below its margin of safety intrinsic value
SEC filing link: https://www.sec.gov/edgar/browse/?CIK=1514991&owner=exclude
LGND – LIGAND PHARMACEUTICALS INCORPORATED (HQ: USA/Industry: Biotechnology)
Ligand is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. The company employs research technologies such as antibody discovery technologies, ion channel discovery technology, Pseudomonas fluorescens protein expression technology, formulation science and liver targeted pro-drug technologies to assist companies in their work toward securing prescription drug and biologic approvals.
Recent 10-Year Financial Summary
Revenue: Increased 794%, with 1 declining year
BV: Increased 3,806%, with 1 declining year
Share Count: Decreased -15%
Company does not pay a dividend
To value the business at their current market price the company would need more than a 16% per year growth for the next 10-years
SEC filing link: https://www.sec.gov/edgar/browse/?CIK=886163&owner=exclude
AON – AON PLC (HQ: United Kingdom/Industry: Insurance)
Aon is a leading global professional services firm providing a broad range of risk, health, and wealth solutions. Through its experience, global reach, and comprehensive analytics, the company is better able to help clients meet rapidly changing, increasingly complex, and interconnected challenges.
Recent 10-Year Financial Summary
Revenue: Increased 6%, with 3 declining years
EPS: Increased 86%, with 3 declining years
BV: Decreased -59%, with 6 declining years
FCF: Increased 78%, with 3 declining years
Share Count: Decreased -32%
Dividend: Increased 221%, with 0 declining years
To value the business at their current market price the company would need more than a 19% per year growth for the next 10-years #SEC filing link:
https://www.sec.gov/edgar/browse/?CIK=315293&owner=exclude
CASS – CASS INFORMATION SYSTEMS, INC. (HQ: USA/Industry: IT Services)
Cass Information Systems provides payment and information processing services to large manufacturing, distribution and retail enterprises across the United States. The Company’s services include freight invoice rating, payment processing, auditing, and the generation of accounting and transportation information. Cass also processes and pays facility-related invoices, which include electricity and gas as well as waste and telecommunications expenses, and is a provider of telecom expense management solutions.
Recent 10-Year Financial Summary
Revenue: Increased 32%, with 1 declining year
EPS: Increased 31%, with 2 declining years
BV: Increased 57%, with 1 declining year
FCF: Decreased -6%, with 4 declining years
Share Count: Decreased -7%
Dividend: Increased 127%, with 0 declining years
The stock is fairly valued but does not take into account a sufficient margin of safety
SEC filing link: https://www.sec.gov/edgar/browse/?CIK=708781&owner=exclude